Sanofi US News

- Sanofi US to Donate Up to $100,000 to Patient Organizations -

- Bettis and Miller, Both at Risk for Anaphylaxis, Join Forces with Sanofi US to Introduce Auvi-Q (Epinephrine Injection, USP) and Serve Up Allergy-Friendly Tips for Big Game Parties -

--LeGoo® proprietary gel technology provides clear surgical field for cardiothoracic and vascular surgeons without trauma to blood vessels--

-- Breakthrough device design talks patients and caregivers through the injection process --

- NBA All-Stars Andre Iguodala and Danny Granger and Seven-Time WNBA All-Star Tamika Catchings to Help Raise Awareness about Diabetes -

-- Product acquisition further strengthens Consumer Healthcare Division of Sanofi US --

- Company’s annual Adopt-a-Family drive delivers essential items to local families in need -

- Registries for All Diseases wins $300k to create crowdsourced cross-disease registry -

Pathway to Stop Diabetes to Provide Funding for Innovative Diabetes Researchers

- New Data Presented at American Society of Hematology Annual Meeting Show Activity Against Disease and Symptom Alleviation -

Response Includes Contribution to Three New Jersey Area Organizations

- Two-Dose Series Given at Regularly Scheduled Pediatric Visits Demonstrates Strong Immune Responses -

Growth Platforms(2) reached over 70% of sales

- QIV is the next evolution of influenza vaccine designed to help protect against influenza B, a significant cause of influenza illness and associated complications across all ages, and especially children -

– CDC analysis of 10 influenza seasons indicates use of a four-strain vaccine could have prevented 2.7 million influenza cases, 21 thousand influenza-related hospitalizations and almost 1,400 influenza-related deaths(1) –

Establishment of joint project teams will leverage strengths of academic and industry cross-organizational expertise in all stages of translational research

U.S. Senator Robert P. Casey, Jr. and Former First Lady Of Pennsylvania Ellen Casey Co-Chair Event

- Goal is to select novel clinical development candidates to help stop the global pandemic -